Seeking Alpha

Allergan (AGN -9.4%) dives as management - on today's earnings call - has less than great...

Allergan (AGN -9.4%) dives as management - on today's earnings call - has less than great progress to report on a couple of drugs in development. Regeneron (REGN +12.4%) spikes higher.
Comments (1)
  • lucagrs
    , contributor
    Comments (68) | Send Message
     
    Too bad the CEO sold 80,000 shares on this day, if only he had waited two days more he could have made $1.6 mln more.
    4 May 2013, 10:10 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|